TFC Financial Management’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36 Hold
1
– – ﹤0.01% 1011
2026
Q2
$21 Buy
+1
New +$19 ﹤0.01% 1024

Other funds holding TRAX

TFC Financial Management's TRAX Position: Q3 2026 in Review

TFC Financial Management held its First Tracks Biotherapeutics (TRAX) position steady in Q3 2026 at 1 share worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

TFC Financial Management first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • TFC Financial Management held 1 share of First Tracks Biotherapeutics worth $36 as of Q3 2026.
  • TFC Financial Management left its First Tracks Biotherapeutics share count unchanged in Q3 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #1011 holding.
  • TFC Financial Management first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.